Bioactivity:

ICL-CCIC-0019 is an inhibitor of choline kinase alpha (CHKA). ICL-CCIC-0019 decreases phosphocholine levels and the fraction of labeled choline in lipids, and induces G1 arrest, endoplasmic reticulum stress and apoptosis of cancer cell lines.

CAS nr:

936498-64-5

Purity:

98%

Molecular Weight:

572,47

SMILES:

CN(C1=CC=[N+](CCCCCCCCCCCC[N+]2=CC=C(N(C)C)C=C2)C=C1)C.[Br-].[Br-]

Formula:

C26H44Br2N4

Pathway:

Neuroscience

Target:

AChR